Also in this case, it is believed that copeptin will not replace the currently used heart failure markers—NT-proBNP, hs-cTnT, and others—but measuring it together with other markers may improve diagnosis, assessment of complications, and patient stratification [80,81]. Here, AVP is linked to heart failure.